Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. [electronic resource]
Producer: 20201201Description: 167-175 p. digitalISSN:- 2055-6845
- Administration, Oral
- Aged
- Aged, 80 and over
- Anticoagulants -- administration & dosage
- Atrial Fibrillation -- diagnosis
- Comorbidity
- Factor Xa Inhibitors -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Pyridines -- administration & dosage
- Randomized Controlled Trials as Topic
- Risk Assessment
- Risk Factors
- Stroke -- diagnosis
- Thiazoles -- administration & dosage
- Thromboembolism -- diagnosis
- Time Factors
- Treatment Outcome
- Warfarin -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.